These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 30935958)

  • 1. Impact of N-glycosylation site variants during human PrP aggregation and fibril nucleation.
    Mishra R; Elgland M; Begum A; Fyrner T; Konradsson P; Nyström S; Hammarström P
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):909-921. PubMed ID: 30935958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
    Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
    Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a central role of PrP helix 2 in the nucleation of amyloid fibrils.
    Honda R; Kuwata K
    FASEB J; 2018 Jul; 32(7):3641-3652. PubMed ID: 29401635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
    Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
    Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segments in the Amyloid Core that Distinguish Hamster from Mouse Prion Fibrils.
    Shen HC; Chen YH; Lin YS; Chu BK; Liang CS; Yang CC; Chen RP
    Neurochem Res; 2019 Jun; 44(6):1399-1409. PubMed ID: 30603982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of divalent cations on elk prion protein fibril formation and stability.
    Samorodnitsky D; Nicholson EM
    Prion; 2018 Jan; 12(1):63-71. PubMed ID: 29310497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
    Singh J; Udgaonkar JB
    J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntaxin-6 delays prion protein fibril formation and prolongs the presence of toxic aggregation intermediates.
    Sangar D; Hill E; Jack K; Batchelor M; Mistry B; Ribes JM; Jackson GS; Mead S; Bieschke J
    Elife; 2024 Aug; 13():. PubMed ID: 39109999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal Prion Protein Peptides (PrP(120-144)) Form Parallel In-register β-Sheets via Multiple Nucleation-dependent Pathways.
    Wang Y; Shao Q; Hall CK
    J Biol Chem; 2016 Oct; 291(42):22093-22105. PubMed ID: 27576687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Positively Charged Cluster in the N-terminal Disordered Region may Affect Prion Protein Misfolding: Cryo-EM Structure of Hamster PrP(23-144) Fibrils.
    Lee CH; Saw JE; Chen EH; Wang CH; Uchihashi T; Chen RP
    J Mol Biol; 2024 Jun; 436(11):168576. PubMed ID: 38641239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Structure of the Infectious Prion Protein and Its Propagation.
    Requena JR; Wille H
    Prog Mol Biol Transl Sci; 2017; 150():341-359. PubMed ID: 28838667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural mechanisms of oligomer and amyloid fibril formation by the prion protein.
    Sengupta I; Udgaonkar JB
    Chem Commun (Camb); 2018 Jun; 54(49):6230-6242. PubMed ID: 29789820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryo-EM structure of an amyloid fibril formed by full-length human prion protein.
    Wang LQ; Zhao K; Yuan HY; Wang Q; Guan Z; Tao J; Li XN; Sun Y; Yi CW; Chen J; Li D; Zhang D; Yin P; Liu C; Liang Y
    Nat Struct Mol Biol; 2020 Jun; 27(6):598-602. PubMed ID: 32514176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arg177 and Asp159 from dog prion protein slow liquid-liquid phase separation and inhibit amyloid formation of human prion protein.
    Li XN; Gao Y; Li Y; Yin JX; Yi CW; Yuan HY; Huang JJ; Wang LQ; Chen J; Liang Y
    J Biol Chem; 2023 Nov; 299(11):105329. PubMed ID: 37805139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A valine-to-lysine substitution at position 210 induces structural conversion of prion protein into a β-sheet rich oligomer.
    Kakuda K; Yamaguchi KI; Kuwata K; Honda R
    Biochem Biophys Res Commun; 2018 Nov; 506(1):81-86. PubMed ID: 30336980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Mechanism of Barriers to Interspecies Seeding Transmissibility of Full-Length Prion Protein Amyloid.
    Ma T; Deng J; Ma S; Zhao W; Chang Z; Yu K; Yang J
    Chembiochem; 2019 Nov; 20(21):2757-2766. PubMed ID: 31161647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The native state of prion protein (PrP) directly inhibits formation of PrP-amyloid fibrils in vitro.
    Honda RP; Kuwata K
    Sci Rep; 2017 Apr; 7(1):562. PubMed ID: 28373719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid fibrils from the N-terminal prion protein fragment are infectious.
    Choi JK; Cali I; Surewicz K; Kong Q; Gambetti P; Surewicz WK
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13851-13856. PubMed ID: 27849581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The N-terminal domain of the prion protein is required and sufficient for liquid-liquid phase separation: A crucial role of the Aβ-binding domain.
    Kamps J; Lin YH; Oliva R; Bader V; Winter R; Winklhofer KF; Tatzelt J
    J Biol Chem; 2021 Jul; 297(1):100860. PubMed ID: 34102212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.